Yan Xiao1, Chang Tan2, Xiaoya Nie3, Baifeng Li1, Miao You1, Yunyun Lan4, Liang Tang5. 1. Department of Day Surgery Center, Zhuzhou Central Hospital, Zhuzhou, 412000, China. 2. Department of Gynecology, Zhuzhou Central Hospital, Zhuzhou, 412000, China. 3. Department of General Medicine, Zhuzhou Central Hospital, No. 116 Changjiang Road, Zhuzhou, 412000, China. 4. Department of Intensive Care Unit, Zhuzhou Central Hospital, No.116 Changjiang Road, Zhuzhou, 412000, China. lanyunyunzz@outlook.com. 5. Department of General Medicine, Zhuzhou Central Hospital, No. 116 Changjiang Road, Zhuzhou, 412000, China. cntangliang@outlook.com.
Abstract
PURPOSE: The mechanism underlying postprandial glucagon-like peptide-1 (GLP-1) changes after metabolic surgery remains mostly unclarified. This investigation aimed to address whether the vagus nerve-spleen anti-inflammatory axis is involved in the rise in postprandial GLP-1 levels in type 2 diabetes mellitus (T2DM) rats following metabolic surgery. MATERIALS AND METHODS: T2DM rat model was established with a high-fat diet and a low dose of streptozotocin and subjected to Roux-en-Y gastric bypass (RYGB) and splenic denervation. A mixed-meal tolerance test for postprandial GLP-1 response was performed. TNF-α in the plasma, spleen, and ileum was measured by ELISA, and alpha 7 nicotinic acetylcholine receptor (α7nAChR) expression in the spleen was analyzed by Western blot. RESULTS: Postprandial GLP-1 improvement by RYGB was accompanied by the reduction of TNF-α levels in spleen and ileum and up-regulation of splenic α7nAChR in T2DM rats. Splenic denervation abrogates a rise in postprandial GLP-1 levels in response to the mixed-meal challenge, along with higher TNF-α levels in spleen and ileum and down-regulation of splenicα7nAChR, compared with denervated sham rats. CONCLUSION: Our results reveal that the vagus nerve-spleen anti-inflammatory axis mediates the rise of postprandial GLP-1 response after RYGB through lowering TNF-α contents in the intestinal tissue in T2DM rats.
PURPOSE: The mechanism underlying postprandial glucagon-like peptide-1 (GLP-1) changes after metabolic surgery remains mostly unclarified. This investigation aimed to address whether the vagus nerve-spleen anti-inflammatory axis is involved in the rise in postprandial GLP-1 levels in type 2 diabetes mellitus (T2DM) rats following metabolic surgery. MATERIALS AND METHODS: T2DM rat model was established with a high-fat diet and a low dose of streptozotocin and subjected to Roux-en-Y gastric bypass (RYGB) and splenic denervation. A mixed-meal tolerance test for postprandial GLP-1 response was performed. TNF-α in the plasma, spleen, and ileum was measured by ELISA, and alpha 7 nicotinic acetylcholine receptor (α7nAChR) expression in the spleen was analyzed by Western blot. RESULTS: Postprandial GLP-1 improvement by RYGB was accompanied by the reduction of TNF-α levels in spleen and ileum and up-regulation of splenic α7nAChR in T2DM rats. Splenic denervation abrogates a rise in postprandial GLP-1 levels in response to the mixed-meal challenge, along with higher TNF-α levels in spleen and ileum and down-regulation of splenicα7nAChR, compared with denervated sham rats. CONCLUSION: Our results reveal that the vagus nerve-spleen anti-inflammatory axis mediates the rise of postprandial GLP-1 response after RYGB through lowering TNF-α contents in the intestinal tissue in T2DM rats.
Authors: Daniéla Oliveira Magro; Everton Cazzo; Paulo Gustavo Kotze; Ana Carolina Junqueira Vasques; Carlos Augusto Real Martinez; Elinton Adami Chaim; Bruno Geloneze; José Carlos Pareja; Cláudio Saddy Rodrigues Coy Journal: Obes Surg Date: 2018-02 Impact factor: 4.129
Authors: Mauricio Rosas-Ballina; Mahendar Ochani; William R Parrish; Kanta Ochani; Yael T Harris; Jared M Huston; Sangeeta Chavan; Kevin J Tracey Journal: Proc Natl Acad Sci U S A Date: 2008-07-31 Impact factor: 11.205
Authors: Jared M Huston; Mahendar Ochani; Mauricio Rosas-Ballina; Hong Liao; Kanta Ochani; Valentin A Pavlov; Margot Gallowitsch-Puerta; Mala Ashok; Christopher J Czura; Brian Foxwell; Kevin J Tracey; Luis Ulloa Journal: J Exp Med Date: 2006-06-19 Impact factor: 14.307
Authors: Pierre Larraufie; Geoffrey P Roberts; Anne K McGavigan; Richard G Kay; Joyce Li; Andrew Leiter; Audrey Melvin; Emma K Biggs; Peter Ravn; Kathleen Davy; David C Hornigold; Giles S H Yeo; Richard H Hardwick; Frank Reimann; Fiona M Gribble Journal: Cell Rep Date: 2019-02-05 Impact factor: 9.423
Authors: Petros Katsogiannos; Prasad G Kamble; Urban Wiklund; Magnus Sundbom; Daniel Espes; Ulf Hammar; F Anders Karlsson; Maria J Pereira; Jan W Eriksson Journal: Endocrine Date: 2020-01-26 Impact factor: 3.633